Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid with or without Alfacalcidol in Osteoporosis
NCT03183557Phase 2Unknown
- Sponsor
- Shinshu University
- Start
- Oct 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid, alfacalcidol in osteoporosis, sponsored by Shinshu University. Status: unknown.
02
Drugs
zoledronic acidalfacalcidol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03183557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183557.